再鼎医药公布,于2024年11月13日(美国东部时间),公司就发售向SEC提交初步招股章程补充文件。于2024年11月14日(美国东部时间),公司就发售与包销商订立包销协议,据此,公司同意以发售价向包销商发行及发售合共7,843,137股美国存托股份(代表总面值为470.59美元的78,431,370股相关股份)。每股美国存托股份代表10股普通股为相关股份。每股美国存托股份的发售价为25.50美元...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.